E Hiv Test

Susan G. Komen for the CureÂ® Awards $1.2 Million for Innovative Breast Cancer Research at the Karmanos Cancer Institute and Wayne State University
DETROIT, July 16 /PRNewswire-USNewswire/ -- Four researchers from Detroit, Michigan's Barbara Ann Karmanos Cancer Institute and Wayne State University (WSU) will receive a total of $1.2 million from Susan G.

Genomic Health Presents Six New Studies Including Four Oral Presentations in Breast, Colon and Renal Cancers at American Society of Clinical Oncology
CHICAGO, June 5 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the results of six studies being presented at the American Society of Clinical Oncology (ASCO) Annual Meeting, including an evaluation of biological similarities and differences between stage II and III colon cancer, suggesting a potential role for the Oncotype DX® colon cancer test in patients with stage III disease, pending further study.

Striking the Balance: Community Experts Come Together for High-Level Dialogue on Cancer Care
CHICAGO, June 5 /PRNewswire/ -- Eminent leaders and thinkers in the cancer community came together yesterday at the 2010 American Society of Clinical Oncology (ASCO) annual meeting for a first-of-its-kind roundtable event.


	E Hiv Test

	Home - Site Map - this site is for sale Interested in this domain? I am retiring. ehivtests.com is for sale. Inquire here. Susan G. Komen for the CureÂ® Awards $1.2 Million for Innovative Breast Cancer Research at the Karmanos Cancer Institute and Wayne State University DETROIT, July 16 /PRNewswire-USNewswire/ -- Four researchers from Detroit, Michigan's Barbara Ann Karmanos Cancer Institute and Wayne State University (WSU) will receive a total of $1.2 million from Susan G. Genomic Health Presents Six New Studies Including Four Oral Presentations in Breast, Colon and Renal Cancers at American Society of Clinical Oncology CHICAGO, June 5 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the results of six studies being presented at the American Society of Clinical Oncology (ASCO) Annual Meeting, including an evaluation of biological similarities and differences between stage II and III colon cancer, suggesting a potential role for the Oncotype DX® colon cancer test in patients with stage III disease, pending further study. Striking the Balance: Community Experts Come Together for High-Level Dialogue on Cancer Care CHICAGO, June 5 /PRNewswire/ -- Eminent leaders and thinkers in the cancer community came together yesterday at the 2010 American Society of Clinical Oncology (ASCO) annual meeting for a first-of-its-kind roundtable event.		Do Bacteria Cause Cancer? Microbes are all around us, on our skins, in our nasal passages and in our intestines, and even in our blood and tissues. Survivors Join Movement to Improve Breast Cancer Outcomes Landmark Patient Registry Will Identify Psychosocial Needs of Women With Breast Cancer WASHINGTON, May 4 /PRNewswire-USNewswire/ -- Millions of women with breast cancer now have a new tool to help fight this deadly disease. Breast Cancer Charity Website Offers Breast Cancer Profiler Tool Handy web-based form makes it easy for breast cancer patients to learn about their treatment options. 2nd Annual Albert Szent-Györgyi Prize for Progress in Cancer Research Awarded to Webster K. Cavenee, Ph.D. The National Foundation for Cancer Research (NFCR) announced today that Webster K. Cavenee, Ph.D. has been awarded the 2nd Annual Albert Szent-Györgyi Prize for Progress in Cancer Research. Dr. Cavenee, Director of the Ludwig Institute for Cancer Research and Distinguished Professor at the University of California, San Diego, won the prize for his groundbreaking discoveries regarding the genetic mechanisms of predisposition to human cancer. Subscribe to our Monthly Email Newsletter